4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-292767
Chief Medical Officer sold 5,407 shares at $24.50 ($132,472)
- Chief Medical Officer acquired 5,407 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Janku Filip · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,407 | $13.41 | $72,508 | 66,019 | D |
| 2026-06-30 | Sale : show line 2 in the form 10b5-1 | −5,407 | $24.50 | $132,472 | 60,612 | D |
| Open-market sales · 5,407 sh · avg $24.50 · $132,472 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −5,407 | 81,093 | D |
Loading xslF345X06/ownership.xml…